1. "Ferrata Storti Foundation"
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (25)
  4. Editorial (15)
  5. Review (10)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (292)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Andrew Zelenetz (24)
  3. Martin Tallman (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (12)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (348)
  2. Haematologica Meeting Reports (4)
Publishers
  1. Ferrata Storti Foundation (352)

Results (352)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical response in relapsed/refractory AML patients correlates with leukemic blast mobilization and differentiation induced by BL-8040, a potent CXCR4 antagonist; Results of a phase IIA study
    Meeting Abstract

    Borthakur, G.; Tallman, M. S.; Ofran, Y.; Foran, J.; Uy, G. L.; DiPersio, J. F.; Nagler, A.; Rowe, J. M.; Showel, M. M.; Altman, J. K.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • An evaluation of the CLL-IPI score and comprehensive prognostic factor analysis in patients with R/R CLL in idelalisib phase 3 randomized studies
    Meeting Abstract

    Soumerai, J. D.; Barrientos, J. C.; Hallek, M.; Kipps, T. J.; Jones, J. A.; Xing, G.; Yao, N. S.; Ysebaert, L.; Stilgenbauer, S.; Zelenetz, A. D.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Integrated safety analysis of venetoclax monotherapy in chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Davids, M. S.; Gerecitano, J.; Potluri, J.; Cerri, E.; Kim, S. Y.; Steinberg, M.; Verdugo, M.; Busman, T.; Enschede, S. H.; Mobasher, M.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • ENGAGE-501: Phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Batlevi, C. L.; Kasamon, Y.; Bociek, R. G.; Lee, P.; Gore, L.; Copeland, A.; Sorensen, R.; Ordentlich, P.; Cruickshank, S.; Kunkel, L.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • The European hematology association roadmap for european hematology research: A consensus document
    Journal Article

    Engert, A.; Balduini, C.; Brand, A.; Coiffier, B.; Cordonnier, C.; Döhner, H.; De Wit, T. D.; Eichinger, S.; Fibbe, W.; Green, T.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • The immune microenvironment in hodgkin lymphoma: T cells, B cells, and immune checkpoints
    Journal Article

    Vardhana, S.; Younes, A.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Genetic analysis of five children with essential thrombocytosis identified mutations in cancer-associated genes with roles in transcriptional regulation
    Journal Article

    Kucine, N.; Viny, A. D.; Rampal, R.; Berger, M.; Socci, N.; Viale, A.; Bussel, J. B.; Levine, R. L.; Rapaport, F.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia
    Journal Article

    Rampal, R.; Figueroa, M. E.
    Haematologica (2016)

    Fulltext@MSK | Save
  • Survival in multiple myeloma patients who develop second malignancies: A population-based cohort study
    Journal Article

    Jonsdottir, G.; Lund, S. H.; Björkholm, M.; Turesson, I.; Wahlin, A.; Mailankody, S.; Blimark, C.; Hultcrantz, M.; Porwit, A.; Landgren, O.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Epigenetic regulators and their impact on therapy in acute myeloid leukemia
    Journal Article

    Pastore, F.; Levine, R. L.
    Haematologica (2016)

    Fulltext@MSK | Save